Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
Colorcon
UBS
Accenture
Mallinckrodt
Daiichi Sankyo
Boehringer Ingelheim
US Army

Generated: July 16, 2018

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of cholestyramine patent protection?

Cholestyramine
is the generic ingredient in eight branded drugs marketed by Parke Davis, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms Usa Inc, Teva Pharms, Upsher-smith Labs, Bristol Myers, and Apothecon, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Seven suppliers are listed for this compound.
Pharmacology for cholestyramine
Synonyms for cholestyramine
CHEMBL2110633
HGMSJMJPXGGEBP-UHFFFAOYSA-N

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-001 Jul 9, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz LOCHOLEST cholestyramine POWDER;ORAL 074561-002 Aug 15, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva CHOLESTYRAMINE cholestyramine POWDER;ORAL 074347-001 May 28, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm CHOLESTYRAMINE cholestyramine POWDER;ORAL 077204-002 Aug 26, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071621-001 May 26, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071739-001 May 26, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Covington
Cerilliant
Harvard Business School
Fuji
McKesson
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.